ClinicalTrials.gov
ClinicalTrials.gov Menu

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00478465
Recruitment Status : Unknown
Verified August 2007 by Stanford University.
Recruitment status was:  Active, not recruiting
First Posted : May 24, 2007
Last Update Posted : August 31, 2007
Sponsor:
Information provided by:
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : August 2007